Mostrando 10 resultados de: 12
Filtros aplicados
Subtipo de publicación
Article(12)
Publisher
Anti-Cancer Agents in Medicinal Chemistry(2)
Bioorganic and Medicinal Chemistry(2)
Combinatorial Chemistry and High Throughput Screening(1)
Current Alzheimer Research(1)
Current Medicinal Chemistry(1)
Área temáticas
Farmacología y terapéutica(10)
Enfermedades(3)
Funcionamiento de bibliotecas y archivos(3)
Medicina y salud(2)
Ginecología, obstetricia, pediatría, geriatría(1)
Área de conocimiento
Descubrimiento de fármacos(6)
Cáncer(5)
Farmacología(4)
Relación cuantitativa estructura-actividad(2)
Biología molecular(1)
Origen
scopus(12)
Chemoinformatics in anti-cancer chemotherapy: Multi-target QSAR model for the in silico discovery of anti-breast cancer agents
ArticleAbstract: The discovery of new and more efficient anti-cancer chemotherapies is a field of research in expansiPalabras claves:Anti-BC activity, BC cell lines, In silico design, linear discriminant analysis, mt-QSAR, quantitative contributionsAutores:Alejandro Speck-Planche, Kleandrova V.V., Luan F., Natalia Dias Soeiro Cordeiro M.Fuentes:scopusChemoinformatics in multi-target drug discovery for anti-cancer therapy: In silico design of potent and versatile anti-brain tumor agents
ArticleAbstract: A brain tumor (BT) constitutes a neoplasm located in the brain or the central spinal canal. The numbPalabras claves:Anti-BT activity, Atom-centered fragments, brain tumor, BT cell lines, chemoinformatics, Drug-receptor interactions, Fragment, Functional group counts, Linear additivity, linear discriminant analysis, Multi-target QSAR, quantitative contributions, ROC curve, Spectral moments, Substructural alertsAutores:Alejandro Speck-Planche, Kleandrova V.V., Luan F., Natalia Dias Soeiro Cordeiro M.Fuentes:scopusAbelson tyrosine-protein kinase 1 as principal target for drug discovery against leukemias role of the current computer-aided drug design methodologies
ArticleAbstract: The discovery of anti-cancer agents is an area which continues in accelerated expansion. Leukemias (Palabras claves:artificial neural networks, Fragments, In silico design, Inhibitors, Kinase, Leukemias, linear discriminant analysis, Molecular docking, QSAR, quantitative contributionsAutores:Alejandro Speck-Planche, Luan F., Natalia Dias Soeiro Cordeiro M.Fuentes:scopusFragment-based QSAR model toward the selection of versatile anti-sarcoma leads
ArticleAbstract: A sarcoma is a type of cancer which is originated from the connective tissue cells. With the time, sPalabras claves:Anti-sarcoma activity, Fragments, linear discriminant analysis, Multi-target QSARAutores:Alejandro Speck-Planche, Kleandrova V.V., Luan F., Natalia Dias Soeiro Cordeiro M.Fuentes:scopusDiscovery of Anti-Alzheimer agents: Current Ligand-Based approaches toward the design of acetylcholinesterase inhibitors
ArticleAbstract: Alzheimer's disease (AD) is a neurodegenerative disorder characterized by progressive dementia and lPalabras claves:3D-QSAR, AChE inhibitors, Fragments, linear discriminant analysis, QSARAutores:Alejandro Speck-Planche, Luan F., Natalia Dias Soeiro Cordeiro M.Fuentes:scopusMulti-target drug discovery in anti-cancer therapy: Fragment-based approach toward the design of potent and versatile anti-prostate cancer agents
ArticleAbstract: Prostate cancer (PCa) is the second-leading cause of cancer deaths among men in the around the worldPalabras claves:Fragments, linear discriminant analysis, Multi-target QSAR, Prostate cancer, quantitative contributionsAutores:Alejandro Speck-Planche, Kleandrova V.V., Luan F., Natalia Dias Soeiro Cordeiro M.Fuentes:scopusMulti-target inhibitors for proteins associated with Alzheimer: In silico discovery using fragment-based descriptors
ArticleAbstract: Alzheimer disease (AD) is one of the most common and serious neurodegenerative disorders in humans.Palabras claves:Anti-AD agents, Fragment, linear discriminant analysis, Mt-inhibitors, QSAR, quantitative contributionsAutores:Alejandro Speck-Planche, Kleandrova V.V., Luan F., Natalia Dias Soeiro Cordeiro M.Fuentes:scopusUnified multi-target approach for the rational in silico design of anti-bladder cancer agents
ArticleAbstract: Bladder cancer (BLC) is a very dangerous and common disease which is characterized by an uncontrollePalabras claves:artificial neural networks, bladder cancer, Fragments, In silico design, linear discriminant analysis, Molecular descriptors, Mt- QSAR, quantitative contributionsAutores:Alejandro Speck-Planche, Kleandrova V.V., Luan F., Natalia Dias Soeiro Cordeiro M.Fuentes:scopusSilico discovery and virtual screening of multi-target inhibitors for proteins in mycobacterium tuberculosis
ArticleAbstract: Mycobacterium tuberculosis (MTB) is the principal pathogen which causes tuberculosis (TB), a diseasePalabras claves:Anti-TB activity, bioinformatics, chemoinformatics, Fragment contributions, Inhibitors, linear discriminant analysis, mt-QSAR, Protein sequenceAutores:Alejandro Speck-Planche, Kleandrova V.V., Luan F., Natalia Dias Soeiro Cordeiro M.Fuentes:scopusRational drug design for anti-cancer chemotherapy: Multi-target QSAR models for the in silico discovery of anti-colorectal cancer agents
ArticleAbstract: The discovery of new and more potent anti-cancer agents constitutes one of the most active fields ofPalabras claves:Anti-CRC activity, Artificial Neural Network, CRC cell lines, In silico design, linear discriminant analysis, mt-QSAR, quantitative contributionsAutores:Alejandro Speck-Planche, Kleandrova V.V., Luan F., Natalia Dias Soeiro Cordeiro M.Fuentes:scopus